Veerhealth Care Wins Rs 454.68 Lakh Skincare Order, Sets 45-Day Execution Timeline
Veerhealth Care has secured a Rs 454.68 lakh face care order from a domestic FMCG company, with execution due within 45 days, according to its BSE filing.

Veerhealth Care Ltd disclosed receipt of a Rs 454.68 lakh skincare products order from an Indian fast-moving consumer goods (FMCG) company in a BSE filing dated October 3, 2026. The order covers the supply of face care products and must be executed within 45 days.
The company withheld the customer's identity under confidentiality terms. Its disclosure identifies the buyer as a domestic entity and classifies the order as domestic business. The accepted order value stated in the company's letter matches the consideration disclosed in the accompanying annexure.
Veerhealth Care described the order as an opportunity for its business and said it anticipated additional growth in turnover. The filing did not quantify that expected growth or provide a revenue recognition schedule.
Supply terms and execution window
The annexure sets out the product category, order size and delivery obligation, giving investors the principal commercial details available in the disclosure:
- Products: Face care products for an Indian FMCG company.
- Accepted value: Rs 454.68 lakh.
- Execution period: 45 days.
- Customer identity: Not disclosed because of confidential terms.
The company listed the same 45-day period both under the order's significant terms and under the stipulated execution timeline. It did not state a separate calendar deadline for completion.
The disclosure concerns receipt of the order. It does not report completed supplies or revenue already earned from this contract.
No related-party transaction
Veerhealth Care stated that its promoters, promoter group and group companies have no interest in the entity awarding the order. It also confirmed that the contract does not constitute a related-party transaction.
The company submitted the disclosure under Regulation 30, read with Schedule III of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and the applicable SEBI master circular dated November 11, 2024.
Managing Director Bhavin S. Shah signed the filing and its annexure. Veerhealth Care's BSE scrip code is 511523.
